Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

1.0K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

21
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
21
Teratogenicity01:07

Teratogenicity

2.6K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Racial Differences in Adverse Pregnancy Outcomes and Incident Hypertension: A Mediation Analysis.

Journal of the American Heart Association·2026
Same author

Aspirin and bleeding risk in pregnancy: a clinical review.

Seminars in perinatology·2026
Same author

Association Between Resident Involvement in Cesarean Delivery, Complications, and Operative Times.

O&G open·2026
Same author

Investigating Perineal Gap as a Novel Measure of Level III Pelvic Floor Support.

Urogynecology (Philadelphia, Pa.)·2026
Same author

Treatment of opioid use disorder in pregnancy among individuals with and without co-occurring stimulant use disorder: A retrospective cohort study.

Journal of substance use and addiction treatment·2026
Same author

From the Guest Editor.

Delaware journal of public health·2026
Same journal

Regenerative Cell and Cell-Free Therapies for Necrotizing Enterocolitis: Progress Toward Clinical Translation.

American journal of perinatology·2026
Same journal

WIC Participation and the Education-Related Gap in Adverse Neonatal Outcomes: A Population-Based Cohort Study.

American journal of perinatology·2026
Same journal

Low-Dose Aspirin Prophylaxis for Preeclampsia and the Risk of Postpartum Hypertensive Outcomes: A Propensity Score Analysis.

American journal of perinatology·2026
Same journal

Cystic Periventricular Leukomalacia in Preterm Infants: Clinical Risks, Heart Rate, and Oxygenation Patterns.

American journal of perinatology·2026
Same journal

International consensus curriculum and competency framework for maternal point-of-care ultrasound training.

American journal of perinatology·2026
Same journal

From InSurE to MIST: A Quality Improvement Initiative in a Level IV NICU.

American journal of perinatology·2026
See all related articles

Related Experiment Video

Updated: Jul 31, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.8K

Maternal Morbidity Risk Factors in Nulliparas.

Audrey A Merriam1, Torri D Metz2, Amanda A Allshouse2

  • 1Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University, New Haven, Connecticut.

American Journal of Perinatology
|May 7, 2023
PubMed
Summary
This summary is machine-generated.

Maternal morbidity affects over 18% of first-time mothers, with Black race, obesity, and pre-existing conditions like diabetes and hypertension being significant risk factors. Early identification of these risks is crucial for better pregnancy outcomes.

More Related Videos

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.4K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

142

Related Experiment Videos

Last Updated: Jul 31, 2025

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development
08:50

A Murine Model of Fetal Exposure to Maternal Inflammation to Study the Effects of Acute Chorioamnionitis on Newborn Intestinal Development

Published on: June 24, 2020

3.8K
A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis
06:19

A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

Published on: January 7, 2018

10.4K
Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes
04:08

Mouse Model of Surgical Uterine Injury and Subsequent Pregnancy Outcomes

Published on: June 27, 2025

142

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Epidemiology

Background:

  • Severe maternal morbidity impacts 50-100 individuals in the U.S. for every maternal death.
  • Identifying specific risk factors for severe maternal morbidity is challenging, especially for nulliparous individuals due to the lack of prior obstetric history.
  • Understanding early pregnancy risk factors is crucial for proactive maternal care.

Purpose of the Study:

  • To investigate the association between first-trimester sociodemographic factors and laboratory results with maternal morbidity in nulliparous individuals.
  • To identify key predictors of severe maternal morbidity in first-time pregnancies.

Main Methods:

  • Secondary analysis of a large, multicenter prospective observational cohort of nulliparas.
  • Composite maternal morbidity outcome included hypertensive disorders of pregnancy, hemorrhage, infection, venous thromboembolic events, or maternal death within 14 days of delivery.
  • Log-binomial regression was used to calculate adjusted relative risks and 95% confidence intervals for maternal morbidity.

Main Results:

  • 18.2% of the 9,445 nulliparas analyzed experienced composite maternal morbidity.
  • Hypertensive disorders of pregnancy (13.1%) and infection (4.43%) were the most common components of maternal morbidity.
  • Self-identified Black race, first-trimester obesity, pregestational diabetes, chronic hypertension, and chronic kidney disease were significantly associated with increased maternal morbidity risk.

Conclusions:

  • Over one in six nulliparas experience significant maternal morbidity in their first pregnancy.
  • Key risk factors for maternal morbidity in nulliparas include Black race, obesity, and pre-existing conditions such as pregestational diabetes, chronic hypertension, and chronic kidney disease.
  • These findings highlight the need for targeted screening and management strategies for high-risk nulliparous individuals.